Preliminary evaluation of ReLIA Point-of-Care Analyzer for Cardiac Troponin
Investigator: Alan H. Wu, PhD
Sponsor: ReLIA Diagnostics, Inc
Location(s): United States
Measurement of cardiac troponin I (cTnI) is important for the diagnosis of myocardial infarction and risk stratification. cTnI in blood is the most sensitive and specific biochemical marker of myocardial infarction. This study evaluated a point of care machine measuring cardiac troponin.